Overview A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED) Status: Completed Trial end date: 2008-12-01 Target enrollment: Participant gender: Summary This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of MK1006 Phase: Phase 1 Details Lead Sponsor: Merck Sharp & Dohme Corp.